Oral Micronized Progesterone for Perimenopausal Vasomotor Symptoms

口服微粉化黄体酮治疗围绝经期血管舒缩症状

• 批准号: 201471
• 负责人: Prior Jerilynn C
• 金额: $ 27.04万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-03-01 至 2014-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=201471&lang=en
• 关键词: Menopausal Transition; Oral Micronized Progesterone; Perimenopause; Quality Of Life; Randomized Controlled Trial; Vasomotor Symptoms (Hot Flushes And Night Sweats)

Perimenopausal hot flushes affect an estimated 2 million Canadian women and 200 000 experience severe symptoms that strongly disturb sleep and quality of life. Although hot flushes and night sweats begin in perimenopause (the transition to menopause) almo

据估计，约有200万加拿大妇女患有围绝经期潮热，20万人出现严重症状，严重干扰睡眠和生活质量。虽然潮热和盗汗开始在围绝经期（过渡到更年期），但